TET2 and acute myeloid leukemia: Despite the revelation of widespread TET mutations and deregulated TET expression in human cancer, the effect on 5mC in these malignancies is still debated, as Ko et al. [47] and Figueroa et al. [48] observed conflicting results of 5mC changes in TET2 mutant acute myelogenous leukemias.